The absorption of
isoniazid is modestly reduced by aluminium hydroxide (about 25%), less so by
magaldrate, and not affected by aluminium/magnesium hydroxide tablets or didanosine chewable tablets (formulated with an antacid buffer).
The
clinical importance of the modest reductions in
isoniazid levels is uncertain, but it is likely to be small.